Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.
暂无分享,去创建一个
S. Kantarci | R. Kanagal-Shamanna | R. Kolhe | P. Miron | A. Chaubey | D. V. Van Dyke | Lu Wang | K. Chun | D. Wolff | D. Dash | G. Wenger